Pharmaceutical Industry News | The Pharmaletter
WEBSep 5, 2024 · Centivo secures $75 million to expand affordable healthcare. Healthcare plan provider Centivo has raised $75 million in equity and debt financing to support its goal of offering affordable care to employees and their families. 25 September 2024. More Pharmaceutical News >. 24 September 2024. 22 September 2024.
Pharma, Biotech and Generics Industry News | The Pharmaletter
WEBSep 17, 2024 · Italian biotech Genespire—which is developing off-the-shelf gene therapies for pediatric patients affected by genetic diseases—has announced the closing of a 46.6 million euros ($52 million) Series B financing. 25 September 2024. Healthcare plan provider Centivo has raised $75 million in equity and debt financing to support its goal of ...
Special Reports - The Pharma Letter
WEBJun 17, 2020 · Our latest Special Report is a review of key factors impeding progress of US biosimilar adoption written by Helen Ji, an associate at Schiff Hardin LLP, Rekha Hanu, executive director and chief IP counsel at Akorn Pharmaceuticals and Christine Simmon, SVP for policy and strategic alliances at the Association for Accessible Medicines. 4 …
Cyclo Therapeutics | The Pharmaletter
WEBAug 23, 2024 · Cyclo's lead therapeutic asset, Trappsol Cyclo, is a proprietary formulation of hydroxypropyl beta cyclodextrin, and in multiple clinical studies has shown encouraging results to effectively manage the transportation of cholesterol. As of Q3 2024, it is being evaluated in clinical trials for the potential treatment of Niemann-Pick Disease Type ...
EMA drug regulation and approval news | The Pharmaletter
WEBSep 21, 2024 · AstraZeneca’s Marketing Authorization Application (MAA) for sipavibart has been accepted under an accelerated assessment procedure by the European Medicines Agency (EMA), for the pre-exposure prophylaxis (prevention) of COVID-19 in immunocompromised patients. 1 July 2024.
About The Pharma Letter | The Pharmaletter
WEB5 days ago · The Pharma Letter offers high value news and insights for people with a professional interest in the global pharmaceutical, biotech, generic and biosimilar industries. Headquartered in London, the company draws from a network of foreign correspondents, with healthcare journalists around the world providing insight on local markets.
Annual revenue of top 10 big pharma companies
WEBMar 3, 2020 · Below is a graph of this year’s top 10 pharma companies, ranked by pharmaceutical revenue, along with a table with more on their performance compared to last year. Pfizer (NYSE: PFE) maintained pole position with full year revenues of $51.75 billion, but sales declined by 4% year-on-year as key …
Bioprocessing Summit | The Pharmaletter | The Pharmaletter
WEBAug 19, 2024 · Bioprocessing Summit. Visit event website. 19 August 2024 22 August 2024. Boston, MA Sheraton Boston. The Summit brings together thought leaders in bioprocess R&D, scale-up, quality, and analytics. to explore cutting-edge research, exchange insights with industry experts. The Summit features main conference sessions, in …
Targeted Genetics Completes RGene Acquisition
WEB30 June 1996. - Targeted Genetics has completed its acquisition of RGene Therapeutics, following shareholder approval. The former will exchange all outstanding RGene shares for 3.64 million of its unregistered common shares. This article is accessible to registered users, to continue reading please register for free.
FDA authorizes updated Novavax COVID-19 Vaccine
WEBAug 31, 2024 · Shares of US protein-based vaccine developer Novavax (Nasdaq: NVAX) closed up 8.6% and added a further 1.8% to $12.60 in after-hours trading on Friday, on a positive development for its COVID-19 vaccine. The US Food and Drug Administration granted emergency use authorization (EUA) for an updated ...